logo
Inside the unusual, RFK-appointed panel that's deciding on childhood vaccines

Inside the unusual, RFK-appointed panel that's deciding on childhood vaccines

USA Today5 hours ago

The world just got its first look at the inner workings of the new vaccine panel appointed by Health and Human Services Secretary Robert F. Kennedy and their immediate focus: childhood vaccines.
The eight new members of the Advisory Committee on Immunization Practices met for the first time on June 25, where ACIP Chair Martin Kulldorf announced at the top of the meeting how the panel plans to reexamine the childhood immunization schedule.
"The number of vaccines that our children and adolescents receive today exceeds what children in most other developed nations receive and what most of us in this room received when we were children," he said. "In addition to studying and evaluating individual vaccines, it's important to evaluate the cumulative effect of the recommended vaccine schedule."
Kulldorff added the committee will also establish workgroups to investigate vaccines that protect against measles, mumps and rubella and hepatitis B.
Kennedy fired all 17 original members of the committee on June 9 and appointed its new members, which included some vaccine skeptics, a few days later.
Their recommendations will have wide-ranging implications, guiding vaccine requirements for schools and impacting a government program offering free vaccinations for about half of America's kids.
Many experts are concerned the panel's actions will sow doubt in vaccines that have been deemed safe and effective.
More: Trump US CDC nominee backs vaccines as life-saving
'To raise doubt about our traditional pediatric vaccines that have saved millions of lives, particularly during one of the worst measles outbreaks we have had in years, is irresponsible and will cost lives,' said Dr. Gretchen LaSalle, a family physician in Spokane, Washington, who represents the American Academy of Family Physicians for an ACIP workgroup.
The Centers for Disease Control and Prevention panel also reviewed data about COVID-19 vaccines, immediately questioning their safety and effectiveness. They also raised questions about the study design, methodologies and surveillance monitoring systems behind the data, which Dr. Pamela Rockwell, clinical professor of family medicine at the University of Michigan Medical School, addressed as standard of medical research.
"Our efforts, through a very robust system of checks and balances, are to create vaccines and vaccination programs that result in the most benefit with the least harm," said LaSalle, from AAFP.
The committee didn't vote on COVID-19 vaccine recommendations for the fall and isn't expected to reconvene until 'September/October,' according to the CDC website.
'Stakes are simply too high': Criticisms and controversies
Public comment during the meeting was a mix of voices raising criticisms and concerns about potential harm, from different perspectives.
Nurses, pediatricians, public health experts and mothers flooded the public comment portion of the meeting to criticize Kennedy's decision to fire the 17 original ACIP members and advocate the protective benefits of vaccines.
'The Big Cities Health Coalition is deeply concerned that many routine vaccines may soon become inaccessible or unaffordable for millions of Americans if ACIP makes changes based on ideology rather than science,' Chrissie Juliano, executive director of the Big Cities Health Coalition, said during the public comment section. 'The stakes are simply too high to let that happen.'
Others criticized vaccine mandates and medical exemption restrictions.
'With many new members in place, the ACIP must now act to prevent continued harm,' said Kim Mack Rosenberg, general counsel for Children's Health Defense, the anti-vaccine group founded by Kennedy.
The planned vote on a new shot for respiratory syncytial virus, or RSV, was postponed due to time constraints.
The ACIP meeting was held despite a national outcry from health experts, officials and organizations calling for a delay.
Sen. Bill Cassidy, a Louisiana Republican and physician, urged officials to wait until the panel is 'fully staffed with more robust and balanced representation – as required by law – including those with more direct relevant experience.'
'Although the appointees to ACIP have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology,' Cassidy, the chairman of the Senate Committee on Health, Education, Labor, and Pensions, said in a social media post. 'In particular, some lack experience studying new technologies such as mRNA vaccines, and may even have a preconceived bias against them.'
Contributing: Ken Alltucker, USA TODAY.
Adrianna Rodriguez can be reached at adrodriguez@usatoday.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How PR Companies in India Are Transforming Health Care Communication
How PR Companies in India Are Transforming Health Care Communication

Time Business News

timean hour ago

  • Time Business News

How PR Companies in India Are Transforming Health Care Communication

In today's fast-moving and highly competitive market environment, Indian PR agencies are powerful players in fueling brand visibility, reputation, and credibility. With the advent of digital platforms and the complexification of human behavior, businesses increasingly turn to expert public relations agencies to ensure that their narratives are not just being heard but remembered. Whether your organization is a start-up looking for media coverage, a heritage brand looking to change its image, or a health care facility handling sensitive stories, the Indian PR community offers an impressive array of capabilities and imagination. India's economic diversification and development of industries like IT, e-commerce, pharma, and wellness have generated demand for advanced communication solutions. This has catalyzed the emergence of boutique as well as full-service PR companies in India that offer top-level services like media relations, crisis communication, brand creation, corporate social responsibility publicity, and online PR. Indian PR firms today are not just operating locally but are now cooperating with global brands that are coming onto the continent. Their cultural sensitivity, local media, and multilingual storytelling give them an edge in the global PR market. Among the top cities of this PR revolution are Bangalore—India's Silicon Valley. The growth in the number of PR companies in Bangalore is an indicator of the city's growing business world. From health technology and technology startups to real estate giants, Bangalore companies are spending increasing amounts of money on structured PR tactics to be heard in the cacophonous digital and offline media spaces. These agencies combine technologically powered intelligence and human storytelling to help brands communicate with both national and specialty audiences. No industry is as vulnerable and open to criticism as health care is, and in that regard, public relations is priceless. Public Relations in Health Care is not optional—it is a must. Hospital and pharmaceutical firms, medical device manufacturers, and health tech startup companies can rely on PR to become credible and reliable participants in the highly scrutinized health care industry. Good health care PR is all about educating the public, simplifying complicated medical information, handling crises (like COVID-19), and aligning communications with moral values. Indian health care PR agencies are helping brands humanize but scientifically accurately make their messages—shortening the gap between innovation and the final consumer. Among agencies that are making a large impact in this space is MediagraphicsPR. Based in India, the agency has a reputation for tailored communications solutions across sectors like technology, health care, SaaS, and consumer stands out in its fact-based storytelling, strong media relationships, and multi-platform brand building strategies. The company has worked with new and established brands alike, offering each client a communication framework that is tailored to its individual goals and audience. The Public Relations in Health Care work of the company has been noteworthy. Right from launching new health platforms to being sensitive to patient stories, MediagraphicsPR demonstrates what thoughtful PR can have an impact on not just business growth but public health. The evolution of PR companies in India has paralleled the evolution of Indian business—from product-led to purpose-led. As sectors like health care, technology, and education keep evolving, the contribution of PR is more important than ever before. Whether you are a Bangalore startup company, a health care business seeking to build trust, or a pan-India business seeking media outreach, strategic public relations—through the direction of agencies like MediagraphicsPR—can bridge the gap between what your firm offers and what your public is concerned with. TIME BUSINESS NEWS

RFK's vaccine panel to spend days discussing and voting on an ingredient we barely use anymore
RFK's vaccine panel to spend days discussing and voting on an ingredient we barely use anymore

Yahoo

time2 hours ago

  • Yahoo

RFK's vaccine panel to spend days discussing and voting on an ingredient we barely use anymore

Health and Human Services Secretary Robert F. Kennedy Jr.'s vaccine advisory panel will spend days discussing and voting on an ingredient we barely use anymore. Kennedy, a vaccine skeptic, has recently overhauled the Advisory Committee for Immunization Practices, which is responsible for evaluating the safety, efficacy and clinical need of vaccines and then presenting its findings to the Centers for Disease Control and Prevention. He removed all 17 committee members earlier this month and replaced them with several people who have been critical of vaccines. Kennedy had said his picks were 'committed to evidence-based medicine, gold-standard science, and common sense.' The new committee members are now looking at a preservative called thimerosal, which is barely used in vaccines anymore. Thimerosal was introduced in the 1930s to prevent bacterial contamination in vaccines. The preservative began getting phased out of vaccines in the early 2000s. CNN reported that, at the time, there were concerns about whether the mercury-based preservative could cause neurotoxicity when used in childhood vaccines. Some critics suggested a link between thimerosal and autism. Kennedy was among those critics who published a book in 2014 about thimerosal, in which he rejected the findings of a 2004 Institute of Medicine report which concluded there was no 'causal relationship' between thimerosal and autism, according to CNN. He called for the 'immediate removal of mercury – a known neurotoxin – from vaccines,' in his book. The CDC said the Food and Drug Administration's recommendation to remove thimerosal from childhood vaccines was a 'precautionary measure' and that the agency found 'no evidence of harm.' The CDC also said thimerosal is safe and that there is no link between the preservative and autism. This flu season, 94 percent of flu shots did not contain thimerosal, per the CDC. CNN reported the vaccine advisory committee was to meet on Wednesday and Thursday to discuss thimerosal. They will vote on whether to ban the preservative on Thursday, per ABC News. Dr. Jason Goldman, president of the American College of Physicians and a liaison member to the vaccine advisory committee, told ABC News, 'It's just a mystery to me why they're even having this on the agenda."

RFK Jr's vaccine panel to review long-approved jabs for children
RFK Jr's vaccine panel to review long-approved jabs for children

Yahoo

time3 hours ago

  • Yahoo

RFK Jr's vaccine panel to review long-approved jabs for children

The new members of US Health Secretary Robert F Kennedy Jr's panel of vaccine advisers will review long-approved immunisation schedules for children and teens. The seven members of the Advisory Committee on Immunization Practices (Acip) met for the first time on Wednesday, weeks after Kennedy ousted all 17 of their predecessors. The Acip recommends who should be vaccinated and when to the US Centers for Disease Control and Prevention (CDC). Ahead of the meeting, public health experts and politicians raised concerns about the qualifications of the new members - several of whom are vaccine critics. The health secretary sparked uproar when he removed all 17 members of the ACIP on 9 June, and then hand-picked eight new members to serve on the panel - including one who dropped out hours before the first meeting. Wednesday's meeting began with the new chair Dr Martin Kulldorff telling the panel that he was fired from his job as a professor at Harvard University because he refused to get a Covid-19 vaccine. Dr Kulldorff also announced the panel would launch new working groups to examine child vaccination schedules and vaccines that were approved seven or more years ago. He said it would be reviewed whether it was "wise" to give the hepatitis B vaccines to newborns, a shot proven safe and effective at preventing the infection that causes liver cancer. Vaccine schedules for measles would also be reviewed, he said. Examining vaccines licensed seven or more years ago raises concerns, because it suggests the process to approve them was flawed, said Bill Hanage, a professor of epidemiology at Harvard TH Chan School of Public Health. "I cannot think of any rational reason you would look at that and think it to be the case," he said. The panel was initially meant to vote on recommendations for shots against RSV, a respiratory virus that can be dangerous for infants, but that has been postponed. On Thursday, the group is scheduled to hear a presentation on the use of thimerosal in vaccines given by Lyn Redwood, a former leader of Children's Health Defense, an anti-vaccine group Kennedy used to run. Ms Redwood has been hired by the CDC to work in its vaccine safety office, according to the BBC's US partner CBS News. The decision for the panel to discuss thimerosal, a mercury-based preservative that has not been used in most vaccines for decades, is perplexing, Dr Hanage said. In the past, he said, Acip's members had a wide range of vaccine expertise and would scrutinise vaccine recommendations for months. This time, Kennedy chose for the panel "people that are like him - people in the past who have shown an anti-vaccine bias", said Dr Paul Offit, a former Acip member and director of the Vaccine Education Center at Children's Hospital of Philadelphia. One of the new Acip members was Dr Michael Ross, however he withdrew this week ahead of a review of members' financial holdings, the Department of Health and Human Services said. Kennedy's panel choices have also sparked criticism from Republican Senator Bill Cassidy, a physician who was sceptical of voting to confirm Kennedy as health secretary because of his stances on vaccines. In a post on X, Cassidy said the panel should not proceed with their meeting because of the group's small size and the lack of a CDC director in place to approve their recommendations. "Although the appointees to ACIP have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology," he wrote. "In particular, some lack experience studying new technologies such as mRNA vaccines, and may even have a preconceived bias against them." RFK Jr appoints new US vaccine advisers after sacking committee RFK Jr sacks entire US vaccine committee

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store